This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
These are heady times for using artificialintelligence to extract insights from healthcare data—in particular, from the tidal wave of information coming out of fields like genomics and medical imaging. This story is part of an ongoing Xconomy series on A.I. in healthcare.
This week, we’re focusing on artificialintelligence, one of the buzziest fields in tech. Or, maybe instead, it’s a day filled with long lunches and listless Internet surfing, as you seek out all the interesting articles you missed during the week. Here are a. Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.
Artificialintelligence innovation has become part of our everyday lives—retailers use it to tailor the product recommendations they make; biotech companies hope it can create customized medicine. But its shortcomings, born of human biases, are becoming apparent as well. A new organization called Ada-AI, which is based in.
[ Updated 12/27/18, 9:54 am ] Manoj Saxena is bullish on artificialintelligence. startup CognitiveScale and managing director of The Entrepreneur Fund , which makes investments in early-stage machinelearning companies, Saxena believes A.I. As chairman of Austin, TX-based A.I.
That plan folds the startup into the ranks of biopharma firms that are trying to use artificialintelligence, machinelearning, and other computing tools to discover drugs—specifically, in Erasca’s case, precision. Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.
Then the tech industry moved on, and marketers crowned data science and machinelearning the Next Big Things (at least until blockchain takes over). In fact, there’s a lot happening in the field, and some of it is linked to the rise of machinelearning and artificialintelligence applications.
Today’s artificialintelligence technologies have demonstrated they’re capable of handling specific tasks, such as identifying pictures of cats or spotting cancer in CT scans. [ Editor’s note: This is part of a series of posts sharing thoughts from technology leaders about 2018 trends and 2019 forecasts.
Entrepreneur-turned-venture capitalist Vinod Khosla made big headlines almost six years ago when he wrote a blog post called “Do We Need Doctors or Algorithms?”
So far, the story of IBM Watson Health has been mostly about growth and potential. So is the scope of the new IBM collaboration, which spans cancer (breast, lung, and others), eye health, diabetes, brain disease, and cardiovascular disease. LeGrand calls the approach “augmented intelligence,” as opposed to artificialintelligence.
Launched four years ago, the Nanodegree courses allow students worldwide to gain expertise in areas such as data analytics, machinelearning, and autonomous flight engineering by completing coursework that can take as little as six months.
Artificialintelligence and cybersecurity remained front and center in tech, as new. Storylines in various sectors helped shape the overall narrative in 2018. Cell and gene therapies, cancer immunotherapy, and digital medicines made substantial progress in healthcare. Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.
From Microsoft and IBM to Alphabet’s unit X and Canada’s D-Wave Systems, companies are racing to build powerful quantum computers that may solve problems beyond the capacity of the most sophisticated conventional processors, and do it much faster.
Artificialintelligence is a booming business in 2017, but one that also comes with significant baggage in the form of public misunderstanding, potential job losses, and fear. Last fall, A.I.
Artificialintelligence is poised to infiltrate nearly all aspects of human life. Given this development, technologists are focusing on how to ensure the technology usage is governed by ethics. The general rule is that power begets responsibility,” says Michael Stewart, founder and CEO of Lucid AI , an AI startup in Austin. “If
Sebastian Thrun first made his mark on autonomous vehicle development at the dawn of that industry, when he led a Stanford team whose robot car Stanley won the $2 million DARPA Grand Challenge in 2005 by racing driverless through the Mojave Desert for 132 miles.
in 2012, Hylton led a team that developed BrainOS, software technology designed to enable robotic systems to adapt to their environments and learn from humans. After joining Brain Corp. At Brain Corp., Before joining Brain Corp., Hylton was a program manager for the Defense Advanced Projects Agency (DARPA).
The food we buy in grocery stores and restaurants has a story to tell about where it came from and each step it took on its journey to your dinner table. Blockchain technology can help tell that tale. The story many food companies want to tell these days is about safety.
CyberX, an industrial “Internet-of-things” security startup, has raised $18 million in a funding round led by the venture arm of chip-maker Qualcomm (NASDAQ: QCOM ) and Inven Capital, a cleantech and new energy fund based in Prague, the Czech Republic.
Nobel Laureate David Baltimore. Microbiome AND supercomputer pioneer Larry Smarr. Intellectual Ventures’ Nathan Myhrvold. Nicole Glaros of Techstars. These are just a few of the visionary speakers who will be headlining Xconomy’s sixth annual Napa Summit.
After Facebook posted a record profit of almost $7 billion in the fourth quarter on nearly $17 billion in revenue last week, an early investor, former advisor to CEO Mark Zuckerberg, and current shareholder said he’s making it a mission to “fix’’ the 15-year-old tech giant.
With public interest in artificialintelligence technologies on the rise, five of the world’s largest corporations—vying against each other in so many spheres—are banding together to support research on the ethical and societal issues raised by machines with increasingly human-like capabilities.
—IBM’s Watson Health group said that a commercial product could arrive in 2017 that uses machinelearning to digest patient scans, medical records, and other information to help doctors with care decisions.
There is no Obamacare replacement, at least not as of this writing. The Senate Republicans are fractured, with a handful of conservatives and moderates each giving a cold shoulder to their chamber’s version of healthcare reform, the Better Care Reconciliation Act.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content